Cytological examination of pleural cavity lavage accompanied by the study of gene promoter hypermethylation of p16 and O6-methylguanine-DNA- methyltransferase genes in diagnostics of non-small cell lung cancer metastatic changes into pleura

Wspolczesna Onkologia

Volumn 16, Issue 4, 2012, Pages 322-327

  Kaczmarczyk, Grzegorz ^a   Lewandowski, Roman ^a   Trautsolt, Wanda ^a   Ziółkowski, Adam ^a   Kozielski, Jerzy ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Cytology; DNA methylation; Lung cancer; O(6) methyl guanine DNA methyltransferase; p16 gene; Pleura

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P16;

ADULT; AGED; ARTICLE; CYTOPATHOLOGY; DNA METHYLATION; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PLEURA CAVITY; PLEURA METASTASIS; PROMOTER REGION; SMOKING;

EID: 84867681898     PISSN: 14282526     EISSN: None     Source Type: Journal    
DOI: 10.5114/wo.2012.30061     Document Type: Article

References (29)

1. Wistuba II, Gazdar AF. Characteristic genetic alternations in lung cancer. In: Driscoll B, ed. Lung cancer. Humana Press Inc., New Jersey 2003; 3-28.
2. Jabłońska J, Jesionek-Kupnicka D. Zmiany epigenetyczne w nowotworach. Onkol Pol 2004; 7: 181-5. (Pubitemid 40561744)
3. Herman JG, Graff JR, Myöhänen S, Nelkin B, Bylin SB. Methylation-specyfic PCR: A noval PCR assay for methylation status of CpG islands. Proc Nat Acad Sci U S A 1996; 93: 9821-6. (Pubitemid 26296693)
4. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000; 60: 5954-8.
5. Higashiyama M, Doi O, Kodama K, Yokouchi H, Tateishi R, Korai T. Pleural lavage cytology immediately after thoracotomy and before closure of the thoracic cavity for lung cancer without pleural effusion and dissemination: clinicopathological and prognostic analysis. Ann Surg Oncol 1997; 4: 409-15. (Pubitemid 127725516)
6. Buhr J, Berghäuser KH, Morr H, Dobroschke J, Ebner HJ. Tumor cells in intraoperative pleural lavage - An indicator for the poor prognosis of bronchogenic carcinoma. Cancer 1990; 65: 1801-4. (Pubitemid 20116653)
7. Kondo H, Asamura H, Suemasu K, Goya T, Tsuchiya R, Naruke T, Yamagishi K, Uei Y. Prognostic significance of pleural lavage cytology immediately after thoracotomy in patients with lung cancer. J Thorac Cardiovasc Surg 1993; 106: 1092-7. (Pubitemid 24018554)
8. Hillerdal G, Dernevik L, Almgren SO, Kling PA, Gustafsson G. Prognostic value of malignant cells in pleural lavage at thoracotomy for bronchial carcinoma. Lung Cancer 1998; 21: 47-52. (Pubitemid 29027856)
9. Satoh Y, Hoshi R, Ishikawa Y, Horai T, Okumura S, Nakagawa K. Recurrence patterns in patients with early stage non-small cell lung cancers undergoing positive pleural lavage cytology. Ann Thorac Surg 2007; 83: 197-202. (Pubitemid 44917896)
10. Enatsu S, Yoshida J, Yokose T, Nishimura M, Nishiwaki Y, Shirakusa T, Nagai K. Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients. Ann Thorac Surg 2006; 81: 298-304. (Pubitemid 41815422)
11. Vicidomini G, Santini M, Fiorello A, Parascandolo V, Calabrò B, Pastore V. Intraoperative pleural lavage: is it a valid prognostic factor in lung cancer? Ann Thorac Surg 2005; 79: 254-7. (Pubitemid 40037480)
12. Eagan RT, Bernatz PE, Payne WS, Pairolero PC, Williams DE, Goellner JR, Piehler JM. Pleural lavage after pulmonary resection for bronchogenic carcinoma. J Thorac Cardiovasc Surg 1984; 88: 1000-3. (Pubitemid 15003651)
13. Okada M, Tsubota N, Yoshimura M, Miyamoto Y, Maniwa Y. Role of pleural lavage cytology before resection of primary lung carcinoma. Ann Surg 1999; 229: 579-84. (Pubitemid 30191758)
14. Okomura M, Okshima S, Kotake Y, Morino H, Kikui M, Yasumitsu T. Intraoperativ pleural lavage cytology in lung cancer patients. Ann Thorac Surg 1991; 51: 599-604.
15. Kjellberg SI, Dresler CM, FoldbergM. Pleural cytologies in lung cancer without pleural effusions. Am Thorac Surg 1997; 64: 941-4. (Pubitemid 27497362)
16. Buhr J, Berghäuser KH, Gonner S, Kelm C, Burkhardt EA, Padberg WM. The prognostic significance of tumor cell detection in intra-operative pleural lavage and lung tissue cultures for patients with lung cancer. J Thorac Cardiovasc Surg 1997; 133: 683-90. (Pubitemid 27167318)
17. Kim YT, Park SJ, Lee SH, Kang HJ, Hahn S, Kang CH, Sung SW, Kim JH. Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung. J Thorac Cardiovasc Surg 2005; 130: 1378.
18. Kim YT, Lee SH, Sung SW, Kim JH. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection? Thorac Surg 2005; 79: 1180-8. (Pubitemid 40431836)
19. Fujiwara K, Fujimoto N, Tabata M, et al. Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin Cancer Res 2005; 11: 1219-25. (Pubitemid 40175774)
20. Safar AM, Spencer H 3rd, Su X, Coffey M, Cooney CA, Ratnasinghe LD, Hutchins LF, Fan CY. Methylation profiling of archived non-small cell lung cencer: A promising prognostic system. Clin Cancer Res 2005; 11: 4400-5. (Pubitemid 40825630)
21. Ng CS, Zhang J, Wan S, Lee TW, Arifi AA, Mok T, Lo DY, Yim AP. Tumor p16M is a possible marker of advanced stage in non-small cell lung cancer. J Surg Oncol 2002; 79: 101-6. (Pubitemid 34111935)
22. Belinsky SA, Grimes MJ, Casas E, Stidley CA, Franklin WA, Bocklage TJ, Johnson DH, Schiller JH. Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum. Br J Cancer 2007; 96: 1278-83. (Pubitemid 46625083)
23. Benlloch S, Galbis-Caravajal JM, Martín C, Sanchez-Paya J, Rodríguez-Paniagua JM, Romero S, Mafe JJ, Massutí B. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion. Cancer 2006; 107: 1859-65. (Pubitemid 44582956)
24. Divine KK, Pulling LC, Marron-Terada PG, et al. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers. Int J Cancer 2005; 114: 400-5. (Pubitemid 40279960)
25. Katayama H, Hiraki A, Aoe K, et al. Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion. Int J Cancer 2007; 120: 2191-5. (Pubitemid 46555857)
26. Furonaka O, Takeshima Y, Awaya H, Kushitani K, Kohno N, Inai K. Aberrant methylation and loss of expression of O-methylguanine-DNA methyltransferase in pulmonary squamous cell carcinoma and adenocarcinoma. Pathol Int 2005; 55: 303-9. (Pubitemid 40910662)
27. Liu Y, Lan Q, Siegfried JM, Luketich JD, Keohavong P. Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia 2006; 8: 46-51.
28. Hong YS, Roh MS, Kim NY, Lee HJ, Kim HK, Lee KE, Kwak JY, Kim JY. Hypermethylation of p16INK4a in Korean non-small cell lung cancer patients. J Korean Med Sci 2007; 22 Suppl: S32-7.
29. Xie GS, Hou AR, Li LY, Gao YN, Cheng SJ. Aberrant p16 promoter hypermethylation in bronchial mucosae as a biomarker for the early detection of lung cancer. Chin Med J (Engl) 2006; 119: 1469-72.